People who are frequently diagnosed with depression may run higher risk of having Alzheimer's disease later as researcher have found that use of antidepressants is more common among people who go on to develop the most common form of dementia.
Antidepressants are frequently initiated in persons with Alzheimer's disease (AD) already before the diagnosis, the findings showed.
"The incidence of antidepressant use was higher in persons with AD than in comparison persons, and it was not explained by history of hospital-treated psychiatric disorders," the researchers said.
The findings by the researchers from University of Eastern Finland was based on 62,104 Finnish persons with Alzheimer's disease diagnosed between 2005 and 2011.
The results were published in International Journal of Geriatric Psychiatry.
The researchers found that antidepressant initiation was more frequent among people with Alzheimer's disease already nine years before the diagnosis than among comparison persons not diagnosed with Alzheimer's disease.
This finding was somewhat surprising. It may be related to more frequent treatment of depressive symptoms because depression has been associated with an increased risk of Alzheimer's disease in previous studies.
Antidepressant use was investigated in the study from nine years before to four years after the diagnosis of Alzheimer's disease.
The difference in antidepressant initiations persisted during the entire follow-up period.
During the 13-year follow-up period, 42 percent of persons with Alzheimer's disease and 22 percent of persons not diagnosed with the disease initiated antidepressant use.
The most commonly used antidepressant group was selective serotonin reuptake inhibitor (SSRI) drugs, followed by mirtazapine.
"Widespread use of antidepressants in persons with AD is concerning as their efficacy is controversial and their use is associated with adverse events," the study noted.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
